# Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

> **NCT04258423** · PHASE3 · TERMINATED · sponsor: **Indiana University** · enrollment: 4 (actual)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT04258423
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-19
- **Primary completion:** 2020-06-27
- **Final completion:** 2020-06-27
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Study was larger than expected and became a burden to faculty and staff resources.
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04258423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04258423, "Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04258423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*